Drug
Aro Inhbe
Aro Inhbe: highest development phase Phase 2, developed by Arrowhead Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Arrowhead Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARO-INHBE NCT07859813 | Phase 2 | Metabolic Dysfunction-Associated Steatohepatitis |
| ARO-INHBE NCT06700538 | Phase 1/2 | Obesity |
Latest
No recent events.
Follow Aro Inhbe on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.